2022
DOI: 10.2196/38088
|View full text |Cite
|
Sign up to set email alerts
|

Supporting Shared Decision-making About Surveillance After Breast Cancer With Personalized Recurrence Risk Calculations: Development of a Patient Decision Aid Using the International Patient Decision AIDS Standards Development Process in Combination With a Mixed Methods Design

Abstract: Background Although the treatment for breast cancer is highly personalized, posttreatment surveillance remains one-size-fits-all: annual imaging and physical examination for at least five years after treatment. The INFLUENCE nomogram is a prognostic model for estimating the 5-year risk for locoregional recurrences and second primary tumors after breast cancer. The use of personalized outcome data (such as risks for recurrences) can enrich the process of shared decision-making (SDM) for personalized… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 35 publications
0
6
0
Order By: Relevance
“…Strategies are required to better establish which patients are at higher risk of recurrence, and whether tailored follow-up based on recurrence risk would improve the value of follow-up. Follow-up models currently under investigation include the use of personalized outcome data in shared decision making and on-demand follow-up [ 18 , 19 ]. In addition, more data is needed on whether or not follow-up strategies are meeting the broader goals of follow-up beyond detection of breast cancer recurrence and second primary tumours but also on goals such as; patient adherence to mammography, compliance to endocrine therapy and management of psychosocial stress for example [ 14 , 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…Strategies are required to better establish which patients are at higher risk of recurrence, and whether tailored follow-up based on recurrence risk would improve the value of follow-up. Follow-up models currently under investigation include the use of personalized outcome data in shared decision making and on-demand follow-up [ 18 , 19 ]. In addition, more data is needed on whether or not follow-up strategies are meeting the broader goals of follow-up beyond detection of breast cancer recurrence and second primary tumours but also on goals such as; patient adherence to mammography, compliance to endocrine therapy and management of psychosocial stress for example [ 14 , 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…Mixed methods were used to perform the process evaluation. This evaluation was embedded within the SHOUT-BC study (see Figure 1 for a graphic overview of the SHOUT-BC study) [10,18,19]. This study was conducted in accordance with local laws and regulations.…”
Section: Methodsmentioning
confidence: 99%
“…The BCS-PtDA was developed in cocreation with relevant stakeholders and consists of three components [10]: (1) a handout sheet with which post-treatment surveillance can be introduced and on which personalized risks for recurrences (estimated using the IN-FLUENCE 2.0 nomogram, https://www.evidencio.com/models/show/2238/nl (accessed…”
Section: Breast Cancer Surveillance Decision Aidmentioning
confidence: 99%
See 2 more Smart Citations